Lavipharm S.A. logo

Lavipharm S.A. (BXA0)

Market Open
10 Aug, 20:00
XFRA XFRA
1. 48
-0.01
-0.6702%
120.45M Market Cap
- P/E Ratio
- Div Yield
1,000 Volume
0 Eps
1.49
Previous Close
Add Transaction
Day Range
1.48 1.48
Year Range
0.71 1.85
Want to track BXA0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BXA0 trading today lower at €1.48, a decrease of -0.6702% from yesterday's close, completing a monthly increase of 3.2033% or €0.05. Over the past 12 months, BXA0 stock gained 65.2174%.
BXA0 is not paying dividends to its shareholders.
Lavipharm S.A. has completed 1 stock splits, with the recent split occurring on Aug 01, 2022.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XBER (EUR).

BXA0 Chart

People also search for

1NL
VRG S.A.
1.24
+0.8163%
FUP
Fuji Pharma Co., Ltd.
9.75
-0.5102%
9F9
Elektro Importoren AS
1.88
+0.2667%
OFH
Orell Füssli AG
148
0%
0CD
Canatu Oyj
6.55
+0.9245%

Lavipharm S.A. (BXA0) FAQ

What is the stock price today?

The current price is €1.48.

On which exchange is it traded?

Lavipharm S.A. is listed on XFRA.

What is its stock symbol?

The ticker symbol is BXA0.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 120.45M.

Has Lavipharm S.A. ever had a stock split?

Lavipharm S.A. had 1 splits and the recent split was on Aug 01, 2022.

Lavipharm S.A. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Vassilis Baloumis CEO
XFRA Exchange
GRS246003008 ISIN
DE Country
300 Employees
- Last Dividend
1 Aug 2022 Last Split
- IPO Date

Overview

Lavipharm S.A., founded in 1911 and headquartered in Paiania, Greece, is an esteemed entity in the global healthcare industry, focusing on the research, development, manufacture, import, marketing, sale, and wholesale of a broad spectrum of pharmaceutical, dermocosmetic, and healthcare products. Catering to both the Greek market and an international clientele, the company has established itself as a key player in providing healthcare solutions directly to physicians and pharmacists. With a rich legacy spanning over a century, Lavipharm S.A. combines its profound experience with innovative practices to bring effective healthcare solutions to the forefront of the industry.

Products and Services

  • Pharmaceutical Products for Specialized Fields
  • Lavipharm S.A. offers a diverse portfolio of pharmaceutical products targeting various critical areas of healthcare such as cardiology, oncology-urology, the central nervous system, and chronic pain management. This encompasses a range of medications designed to meet the therapeutic needs of patients, ensuring efficacy and safety across these core medical specialties.

  • Self-treatment Solutions
  • Understanding the growing trend towards self-care, the company provides a selection of products aimed at self-treatment. These are designed to empower individuals to manage their health proactively, with over-the-counter (OTC) options that are both accessible and reliable, fostering a culture of wellness and preventive care.

  • Prescription Medicines
  • Key to its product lineup, Lavipharm S.A. markets a variety of prescription medicines. These pharmaceuticals are developed based on rigorous research and adherence to industry standards, ensuring that healthcare professionals and patients have access to effective treatment options for a multitude of health concerns.

  • Over-the-Counter (OTC) Products
  • The range of over-the-counter (OTC) products offered by Lavipharm S.A. includes a vast selection of medications and health aids that can be purchased without a prescription. This segment enables consumers to address common health issues promptly and conveniently, enhancing the general wellbeing of the community.

  • LIFELAB CBD
  • Embracing the therapeutic potentials of cannabidiol (CBD), Lavipharm S.A. has ventured into the provision of LIFELAB CBD products. This line represents the company’s commitment to innovation in healthcare, offering scientifically-backed, CBD-infused solutions designed to support a range of health and wellness needs.

Contact Information

Address: 12, Agias Marinas Street, Paiania, Greece, 190 02
Phone: 30 210 66 91 000